• Chlorambucil (SKU B3716): Reliable DNA Crosslinking in Oncol

  2026-07-21

  This article addresses common laboratory challenges in cell viability and cytotoxicity assays, focusing on the reproducibility and mechanistic clarity provided by Chlorambucil (SKU B3716). By dissecting five real-world scenarios, it demonstrates how APExBIO’s high-purity Chlorambucil supports robust experimental design, precise dose-response characterization, and consistent assay performance for cancer researchers.

• Light-Inducible RNA Switches for Precision Gene Therapy Cont

  2026-07-21

  This article examines a rationally designed light-inducible RNA-releasing protein (LIRP) enabling optical regulation of translation in gene therapy contexts. The study’s findings highlight rapid, reversible, and tissue-compatible control of therapeutic gene expression, with major implications for translational regulation and the safety of emerging gene therapies.

• Trelagliptin Promotes Osteoblastic Differentiation via RUNX2

  2026-07-20

  This study identifies trelagliptin, a DPP-4 inhibitor, as a stimulator of osteoblastic differentiation in MC3T3-E1 cells through upregulation of RUNX2 via an AMPK-dependent pathway. The findings suggest a potential therapeutic role for trelagliptin in osteoporosis and provide mechanistic insights that may inform cell isolation protocols in bone research.

• CGF-Induced ROS Disrupts Metabolism to Halt Colorectal Cance

  2026-07-20

  Jiang et al. reveal that Cya-Gly-Fer (CGF), an anthocyanin from purple sweet potato, suppresses colorectal cancer by inducing ROS-mediated metabolic reprogramming and mitochondrial dysfunction. These findings highlight the potential of metabolic targeting in cancer therapy and provide mechanistic insights into cell cycle arrest and apoptosis.

• Vidarabine Monohydrate: Enhancing Antiviral DNA Synthesis In

  2026-07-19

  Vidarabine monohydrate, a DMSO-soluble nucleoside analog, empowers researchers to dissect viral DNA synthesis and replication with unmatched purity and reproducibility. This guide details advanced workflows, protocol optimization, and troubleshooting strategies to unlock its full potential in DNA replication interference, especially in herpes simplex virus research.

• DFO (9H-1,8-Diazafluoren-9-one): Forensic Science Meets Biom

  2026-07-18

  Explore how DFO (9H-1,8-Diazafluoren-9-one) bridges forensic science and biomaterial research, offering superior latent fingerprint chemical detection and new opportunities in tissue engineering. This article uniquely analyzes the intersection of fluorescence chemistry and scaffold design.

• Wnt Agonist 1: Strategic Leveraging of Wnt Signaling in Chem

  2026-07-17

  This thought-leadership article provides a mechanistic and translational roadmap for researchers harnessing Wnt agonist 1 (BML-284) to dissect and model chemoresistance in oncology. By integrating new findings that link canonical Wnt signaling to glutathione metabolism and platinum drug resistance in brain metastases, we offer strategic guidance on experimental design, competitive positioning, and the future of pathway-driven intervention using APExBIO’s Wnt agonist 1.

• Sulfo-Cy5 Carboxylic Acid: Advanced Fluorescent Dye for Life

  2026-07-17

  Sulfo-Cy5 carboxylic acid offers unmatched aqueous solubility and minimized fluorescence quenching, making it the fluorescent dye of choice for high-sensitivity protein and peptide labeling. Its robust performance in advanced imaging and immunological applications, as shown in recent mucosal immunity studies, sets a new standard for translational research workflows.

• PROTAC Nanoplatforms Enhance FLASH-RT via BRD4 Degradation a

  2026-07-16

  Xu et al. introduce a redox-responsive, PROTAC-based nanoassembly that targets BRD4 to sensitize tumors to ultrahigh dose-rate (FLASH) radiotherapy. By promoting intracellular ROS generation and disrupting DNA repair, this approach achieves greater tumor inhibition with minimal toxicity and provides a mechanistic template for designing advanced radiosensitizers.

• circ-Pank1 Drives Dopaminergic Neurodegeneration via miR-7a-

  2026-07-16

  This reference study uncovers a novel regulatory role for circ-Pank1 in Parkinson’s disease progression, demonstrating that circ-Pank1 promotes dopaminergic neuron degeneration by modulating the miR-7a-5p/α-synuclein pathway. These findings highlight circ-Pank1 as a potential target for noncoding RNA-based therapeutic strategies and refine how rotenone-induced models can be leveraged to probe neurodegenerative mechanisms.

• Urolithin A: Advancing Mitochondrial Quality Control Researc

  2026-07-15

  This thought-leadership article explores the mechanistic foundations and strategic opportunities of Urolithin A (3,8-dihydroxy-6H-benzo[c]chromen-6-one) for translational researchers targeting mitochondrial dysfunction, with a particular focus on liver fibrosis and aging. Integrating novel evidence on glutamine metabolism, we provide actionable guidance and protocol insights to help investigators accelerate discoveries and improve experimental reproducibility.

• Benchmarking LNP Platforms for mRNA Delivery: Insights from

  2026-07-15

  Zhu et al. provide a comparative technical and operational evaluation of four bench-scale lipid nanoparticle mixing technologies for mRNA vaccine production. Their work highlights the reproducibility of three micromixing platforms in generating mRNA-LNPs with desirable physicochemical properties and in vivo performance, offering guidance for mRNA delivery and translation efficiency assay development.

• Bismuth Subsalicylate: Mechanism, Evidence, and GI Research

  2026-07-14

  Bismuth Subsalicylate, a non-steroidal anti-inflammatory compound, acts as a potent Prostaglandin G/H Synthase 1/2 inhibitor, making it central to gastrointestinal disorder research. This article provides atomic, evidence-backed insight into its mechanism, key parameters, and experimental limits.

• AMPK Suppresses Autophagy: Rethinking Energy Stress Response

  2026-07-14

  This study overturns the prevailing view of AMPK as a universal autophagy inducer by demonstrating that AMPK actually inhibits the autophagy-initiating kinase ULK1 under energy stress. These findings clarify the nuanced role of AMPK in energy metabolism regulation and have practical implications for metabolic and autophagy research.

• Cucurbitacin I (JSI-124): Advancing STAT3 Inhibition in Canc

  2026-07-13

  Explore how Cucurbitacin I, a potent STAT3 inhibitor, empowers next-generation cancer research through selective pathway targeting and innovative model integration. Discover unique mechanistic insights and advanced assay protocols not covered elsewhere.

14696 records 1/980 page Next 12345 下5页 Last page